- Release Date: 29/05/18 10:00
- Summary: Partnership For Allogeneic Cell-based Cancer Immunotherapies
- Price Sensitive: Yes
- Download Document 77.36KB
- Forums
- ASX - By Stock
- MSB
- Ann: Partnership For Allogeneic Cell-based Cancer Immunotherapies
MSB
mesoblast limited
Add to My Watchlist
0.66%
!
$2.31

Ann: Partnership For Allogeneic Cell-based Cancer Immunotherapies
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.31 |
Change
0.015(0.66%) |
Mkt cap ! $2.950B |
Open | High | Low | Value | Volume |
$2.31 | $2.33 | $2.29 | $4.453M | 1.930M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
70 | 62435 | $2.30 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.31 | 82131 | 54 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
72 | 71524 | 2.300 |
30 | 136591 | 2.290 |
12 | 136907 | 2.280 |
15 | 153159 | 2.270 |
13 | 84238 | 2.260 |
Price($) | Vol. | No. |
---|---|---|
2.310 | 81134 | 52 |
2.320 | 134641 | 16 |
2.330 | 100573 | 14 |
2.340 | 318115 | 12 |
2.350 | 76790 | 13 |
Last trade - 15.43pm 13/08/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |